Part Details | DOXORUBICIN HYDROCHLORIDE INJECTION
6505-01-279-4075
Alternate Parts: NDC55390023701, NDC55390-0237-01, BEDFORD LABS, NDC00013115679, NDC00013-1156-79, ADRIAMYCIN PFS, 6505-01-279-4075, 01-279-4075, 6505012794075, 012794075
| Supply Group (FSG) | NSN Assigned | NIIN | Item Name Code (INC) |
|---|---|---|---|
| 65 | MAY 18, 1988 | 01-279-4075 | 46144 ( DOXORUBICIN HYDROCHLORIDE INJECTION ) |
REFERENCE DRAWINGS & PICTURES
Cross Reference | NSN 6505-01-279-4075
| Part Number | Cage Code | Manufacturer |
|---|---|---|
| NDC55390-0237-01 | 89875 | DEFENSE LOGISTICS AGENCYDIRECTORATE OF MEDICAL MATERIEL |
| BEDFORD LABS | 89875 | DEFENSE LOGISTICS AGENCYDIRECTORATE OF MEDICAL MATERIEL |
| NDC00013-1156-79 | 58750 | ERBAMONT INCADRIA LABORATORIES DIV |
| ADRIAMYCIN PFS | 58750 | ERBAMONT INCADRIA LABORATORIES DIV |
Technical Data | NSN 6505-01-279-4075
| Characteristic | Specifications |
|---|---|
| ACTIVE MEDICAMENT MEDICINAL STRENGTH | BY2.000 MILLIGRAMS DOXORUBICIN HYDROCHLORIDE |
| PRIMARY CONTAINER TYPE | VIAL, SINGLE DOSE |
| PRIMARY CONTAINER CONTENT QUANTITY | 25.000 MILLILITERS |
| SPECIAL FEATURES | ISOTONIC; PRESERVATIVE FREE |
| PROTECTIVE STORAGE FEATURE | ANTINEOPLASTIC DRUG AND REQUIRES REFRIGERATION STORAGE BETWEEN 2 TO 8 DEG CELSIUS |
| SUPPLEMENTARY FEATURES | NOTE D: ANTINEOPLASTIC (CHEMOTHERAPY) DRUG |
| PART NAME ASSIGNED BY CONTROLLING AGENCY | DOXORUBICIN HYDROCHLORIDE INJECTION USP 2MG/ML 25ML VIAL |